Intended for healthcare professionals

  1. Research
  2. Effect of a test-and...
  3. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
CCBYNC Open access
Research

Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)

BMJ 2022; 378 doi: https://doi.org/10.1136/bmj-2022-071230 (Published 07 September 2022) Cite this as: BMJ 2022;378:e071230

Linked Editorial

Can vitamin D protect against covid-19?

Linked Research

Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement

Data supplement

  • Web extra

    • Data Supplement - Supplementary information: study staff, additional tables 1-8, and additional figures 1 and 2

Related articles

EditorialCan vitamin D protect against covid-19?
ResearchPrevention of covid-19 and other acute RTIs with cod liver oil supplementation, a low dose vitamin D supplement

See more

Cited by...

  • Influence of age, sex, body habitus, vaccine type and anti-S serostatus on cellular and humoral responses to SARS-CoV-2 vaccination
  • Long-term symptom profiles after COVID-19 vs other acute respiratory infections: a population-based observational study (COVIDENCE UK)
  • Prevention of COVID-19 with oral vitamin D supplemental therapy in essential healthcare teams (PROTECT): protocol for a multicentre, triple-blind, randomised, placebo-controlled trial
  • Behind the scenes at the Coronavit trial
  • Can vitamin D protect against covid-19?
Back to top